Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Obstetrics & Gynecology
Dermatology
Questions discussed in this category
In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
Does the answer differ if mother remained on TNFi throughout pregnancy?
1 Answer available
25374
Related Topics in Obstetrics & Gynecology
Primary Care
Hematology
Benign Hematology
Pregnancy
Medical Oncology
Women's Mental Health
General Outpatient Psychiatry
Psychiatry
Rheumatology
Endocrinology